Parkman Healthcare Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-243,123
| Closed | -$20.3M | – | 108 |
|
|
2024
Q4 | $20.3M | Buy |
243,123
+1,548
| +0.6% | +$129K | 2.7% | 9 |
|
|
2024
Q3 | $17.7M | Buy |
241,575
+56,547
| +31% | +$4.14M | 2.26% | 11 |
|
|
2024
Q2 | $12.7M | Buy |
185,028
+115,136
| +165% | +$7.89M | 1.7% | 15 |
|
|
2024
Q1 | $4.84M | Sell |
69,892
-116,380
| -62% | -$8.05M | 0.59% | 55 |
|
|
2023
Q4 | $13.3M | Buy |
+186,272
| New | +$13.3M | 1.88% | 19 |
|